“At Soleno, we are focused on developing safe and effective treatment options to address Prader-Willi syndrome and other rare genetic diseases. Patients and families are desperately waiting, and we are committed to doing our part to help.”
Anish Bhatnagar, M.D.
Chief Executive Officer
An equal opportunity employer
As an equal opportunity employer, Soleno Therapeutics, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws.